• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Chan Denies Pharma Influence As WHO Review Proceeds

28/09/2010 by Intellectual Property Watch 3 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

“Never did I see a shred of evidence that financial profits for industry, as opposed to epidemiological and virological data, influenced WHO decisions” on a recent H1N1, or “swine flu” pandemic, World Health Organization Director General Margaret Chan said in opening remarks to the International Health Regulations Review Committee.

She promised to make available all the WHO’s records of its work during the pandemic.

“To some, response measures now look excessive compared with the moderate impact of the pandemic,” but had the “virus turned more lethal, we would be under scrutiny for having failed to protect large numbers of people,” Chan said. She added that vaccine supplies had come “too little, too late” and that much of the developing world had been left “almost entirely unprotected.”

“I personally do not believe that WHO exaggerated the threat,” she said.

The IHR Review Committee is meeting from 27-29 September to continue a review process begun in March to evaluate its efforts during the recent pandemic. The last meeting of the IHR was in July (IPW, WHO, 7 July 2010). Since then, the pandemic has been declared over and for the first time the names of the members of the WHO emergency committee which declared the pandemic have been released (IPW, WHO, 10 August 2010), showing some of the members had ties to industry.

Those most critical of the WHO’s behaviour during the pandemic had decried the WHO’s hiding of these names, saying it could have concealed conflicts of interest in its decision-making process. WHO argued that keeping the experts secret protected them from outside influence.

The full text of Chan’s prepared remarks is available here.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"Chan Denies Pharma Influence As WHO Review Proceeds" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP-Watch Briefs, Language, News, English

Comments

  1. Miles Teg says

    29/09/2010 at 9:09 am

    Like the drunk who looks for his keys where the light is better instead of where he dropped it, this ‘review’ ignores the real issues:

    1) Why did WHO donate ‘free’ virus biodiversity from developing countries to its Collaborating Centres who either patented derivatives or passed them on to commercial entities IN VIOLATION OF ITS OWN GUIDELINES?

    2) Why did WHO along with OIE and WTO issue a statement protecting the pork industry (saying eating pork is safe) when the reason for declaring the pandemic was that this plastic virus can mutate into something much more dangerous/contagious. Funny how WHO specialists think that non-specialists somehow cannot pick out the contradictions – elementary my dear Watson. Its even funnier that the WHO hardly makes such a clear statement on WTO legality of compulsory licenses for HIV/AIDS, yet feels free to make comments on WTO Sanitary and Phytosanitary Standards, in which the WTO ‘court’ has found countries can define their own level of risk tolerance…

    Poor Chan, running an agency that is funded 80% by non-budgetary monies while rich countries hold the purse strings … pay the piper call the tune… But in sympathy with Chan, not even the Council of Europe gets it right… in their inquiry also (for all the hot air), the real issues were sidelined. Its absolutely no use even telling them to look where the keys were dropped instead of where the light is better…

    And for the World’s leading health agency, after years of talks to not have a deal to ensure access to medicines/vaccines for deadly pandemics can make you wonder if the Hippocratic Oath is still applicable…

    And thanks to WHO, the world is as unprepared as ever for a pandemic, especially because the importance of not crying wolf seems to have been forgotten in all this defensive posturing…

    Reply

Trackbacks

  1. Pharma & Biotech Global Week in Review 29 September 2010 from IP Think Tank says:
    29/09/2010 at 12:14 am

    […] Chan denies pharma influence as WHO review proceeds (IP Watch) […]

    Reply
  2. Committee Nears Final Review Of WHO Performance On H1N1 Pandemic | Intellectual Property Watch says:
    29/03/2011 at 5:53 pm

    […] September, Chan denied any pharmaceutical industry influence in the WHO response to the pandemic (IPW, Public Health, 28 September 2010). Related Articles:Committee Examines Undue Influence, Coordination In WHO Pandemic Flu […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.